Myocardial Infarction
Conditions
Keywords
ST-segment elevation myocardial infarction, Primary percutaneous coronary intervention, Clinical outcomes
Brief summary
INcheon-Bucheon cohorT of patients undERgoing primary percutaneous coronary intervention for acute ST-ELevation myocardiaL infARction (INTERSTELLAR) registry is a retrospective, observational, 4-regional-hospital based registry reflecting current practices of management, risk factors, and clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention at cities of Incheon and Bucheon located in the mid-western part of the Korean peninsula between 2007 and 2014.
Detailed description
INcheon-Bucheon cohorT of patients undERgoing primary percutaneous coronary intervention for acute ST-ELevation myocardiaL infARction (INTERSTELLAR) registry is a retrospective, observational, 4-regional-hospital based registry reflecting current practices of management, risk factors, and clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) at cities of Incheon and Bucheon located in the mid-western part of the Korean peninsula between 2007 and 2014. Diagnosis of acute STEMI was based on clinical data findings including typical symptoms, 12-lead electrocardiography, and blood test. Decisions regarding primary PCI were made by at least 2 attending cardiologists at the time of presentation. Demographic data, cardiovascular risk factors, laboratory data and clinical follow-up data were collected. Baseline blood test was obtained and recorded as part of the routine care for patients who visited the emergency room for chest pain and in whom acute coronary syndrome was suspected. Standard medical management was provided by responsible physicians.
Interventions
Primary percutaneous coronary intervention was performed according to the current standard guidelines. Coronary angiography was performed using standard techniques. The use of thrombectomy devices, intravascular ultrasound, intra-aortic balloon pump, and percutaneous cardiopulmonary support was up to the operator.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients diagnosed with acute ST-segment elevation myocardial infarction * Patients treated with primary percutaneous coronary intervention
Exclusion criteria
* Patients diagnosed with Non-ST-segment elevation acute coronary syndrome * Patients treated with thrombolytic therapy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| MACCE | Within the 1 year | Major adverse cardiac and cerebrovascular event (MACCE), defined as the composite of all-cause death, non-fatal myocardial infarction and non-fatal stroke |
Secondary
| Measure | Time frame |
|---|---|
| All-cause death | Within the 1 year |
| Non-fatal myocardial infarction | Within the 1 year |
| Non-fatal stroke | Within the 1 year |
| Ischemic-driven revascularization | Within the 1 year |
| Admission for heart failure | Within the 1 year |
Countries
South Korea